|
News June 8th 2007 Crescent Diagnostics Ltd today announced the publication of a recent study demonstrating the potential of the Bone Quality Test, BQT® to diagnose osteoporosis. Full story >>> March 8th 2007 Crescent Diagnostics Ltd, a revolutionary developer of the Bone Quality Test, BQT® announced today the start of the Fracture Risk Assessment Nail Correlation Study, FRAN. Download the PDF version >>> October 8th 2006 Crescent Diagnostics Ltd., a privately held company developing a new test for bone health, was profiled in Clinica today. Download the PDF version >>> 18th July 2006 Crescent Diagnostics Ltd. has signed an intellectual property option agreement with DeltaNu LLC. This agreement gives Crescent an exclusive option to develop and market products from intellectual property that was invented at the University of Limerick and the University of Wyoming and is jointly held by Crescent and DeltaNu. Full story >>> 13th June 2006 Crescent Diagnostics Ltd., a privately held company developing a new test for bone health, today announced the completion of a £550,000 (€800,000) funding round. Seroba BioVentures (Seroba), a Dublin-based specialist life science venture capital firm led the round in conjunction with a number of private investors. Download the PDF
version or read the full story >>> 9th Nov 2005 CEO Ernest Poku said "The endorsement that comes from this kind of recognition in the medical community cannot be underestimated. We are confident that we will go on to justify their faith in the technology" Crescent Diagnostics is currently carrying out in-house and contract research on the biomarker with a view to enabling commercial applications in the near future. 10th July
2005 |
|
For further information, please or contact us on: Crescent Diagnostics Ltd. |
Website by Prickly Pear Design © 2005 - 2008